These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A Novel Antigen, Otubain Cysteine Peptidase of Leishmania donovani, for the Serodiagnosis of Visceral Leishmaniasis and for Monitoring Treatment Response.
    Author: Kamran M, Ejazi SA, Choudhury ST, Bhattacharyya A, Tanishka K, Pandey K, Das VNR, Das P, da Silva FO, Costa DL, Costa CHN, Rahaman M, Goswami RP, Ali N.
    Journal: Clin Infect Dis; 2021 Oct 05; 73(7):1281-1283. PubMed ID: 33987660.
    Abstract:
    Tests for visceral leishmaniasis (VL) are not uniformly effective for all endemic regions. In a serological assay, a novel antigen, otubain cysteine peptidase, compared with rK39, showed comparable sensitivity with Indian VL serum samples and prominently increased sensitivity with Brazilian samples, as well as improved monitoring of the treatment response.
    [Abstract] [Full Text] [Related] [New Search]